Sandoz To Launch Tyruko Biosimilar For Multiple Sclerosis In

Sandoz To Launch Tyruko Biosimilar For Multiple Sclerosis In Germany On Feb. 1

(RTTNews) - Sandoz (SDZNY), a maker of generic and biosimilar medicines, announced Wednesday the launch of Tyruko (natalizumab) in Germany from Fe...

Related Keywords

Germany , Rebecca Guntern , Polpharma Biologics , European Commission , More Such Health News , President Europe ,

© 2025 Vimarsana